K. Thakkar
发表
Rasesh Y Parikh,
Snehit S. Mhatre,
K. Thakkar,
2010,
Nanomedicine : nanotechnology, biology, and medicine.
J. Brooks,
D. Dill,
J. Leppert,
2020,
Proceedings of the National Academy of Sciences.
E. Rankin,
A. Giaccia,
Saravanan Nandagopal,
2021,
Clinical Cancer Research.
Neutralizing PD-L1 and PD-L2 Enhances the Efficacy of Immune Checkpoint Inhibitors in Ovarian Cancer
E. Rankin,
A. Giaccia,
Saravanan Nandagopal,
2020,
bioRxiv.
E. Rankin,
A. Giaccia,
G. M. Cherf,
2021
.
Developing high-affinity decoy receptors to treat multiple myeloma and diffuse large B cell lymphoma
Hongjuan Zhao,
A. Koong,
M. Liedtke,
2022,
The Journal of experimental medicine.
K. Thakkar,
Kaushik N. Thakkar,
2016
.
E. Graves,
A. Giaccia,
J. Chi,
2021,
Nature Communications.
Parantu K. Shah,
M. Stampfer,
S. Jiang,
2014,
Oncogene.
M. Barton,
K. Thakkar,
Srikanth Appikonda,
2016,
Drug discovery today. Technologies.
E. Rankin,
A. Giaccia,
Q. Le,
2021,
The Journal of clinical investigation.
Parantu K. Shah,
M. Barton,
J. Andersen,
2018,
The Journal of Biological Chemistry.
A. Giaccia,
Yu Liu,
Edward L LaGory,
2018,
Bio-protocol.
Rasesh Y Parikh,
K. Thakkar,
S. Mhatre,
2009
.